Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 12658
Country/Region: Kenya
Year: 2014
Main Partner: Mkomani Clinic Society
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $3,589,589 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Mkomani Clinic Society (MCS) supports the implementation and expansion of high quality HIV Prevention, Care and Treatment Activities at the facility and community level at the Bomu Clinic and 8 affiliated sites in three counties: Mombasa, Kilifi and Kwale, with an estimated population of 3.45 million people and HIV prevalence of 7%. The program goal and objectives are linked to Kenya’s Partnership Framework (PF) and Global Health Initiative (GHI) strategies and are directly aligned to PF pillars 1-3: prevention, care and mitigation, treatment, and systems strengthening. To increase efficiencies, MCS partners with corporate organizations to provide capital investment, which reduces MCS’ capital expenditure. MCS also runs other clinical departments that generate income and provide a point of entry to the HIV program. MCS will increase service integration such as TB/HIV and FP to streamline services and decrease client waiting time. In FY14, MCS will also provide income generating activity (IGA) training to support group members to promote self-sufficiency. In FY14, MCS will audit outreach partners, conducting feasibility studies and building capacity of outreach staff by including them in clinical trainings as a form of preparation to hand over the sites to the county governments and community based organizations (CBO) affiliated with outreach sites. This strategy aims to ensure a smooth transition over time to the county government and CBOs. MCS will continue ensuring all sites utilize Ministry of Health (MOH) guidelines and reporting tools, including expanding into a MOH aligned paperless health information system and electronic medical record system. MCS will also support facilities to implement Kenya’s HIV Quality Strategy and use data for program improvement.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $225,658
Care: Orphans and Vulnerable Children (HKID) $100,000
Care: TB/HIV (HVTB) $166,952
Care: Pediatric Care and Support (PDCS) $106,572
Testing: HIV Testing and Counseling (HVCT) $104,568
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $320,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $225,969
Treatment: Adult Treatment (HTXS) $2,211,044
Treatment: Pediatric Treatment (PDTX) $128,826
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 2,482
C2.1.D By Age: 15+ 2015 25,033
C2.1.D By Age/Sex: <15 Female 2015 1,241
C2.1.D By Age/Sex: <15 Male 2015 1,241
C2.1.D By Age/Sex: 15+ Female 2015 16,522
C2.1.D By Age/Sex: 15+ Male 2015 8,511
C2.1.D By Sex: Female 2015 17,763
C2.1.D By Sex: Male 2015 9,752
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 27,515
C2.1.D Sum of Age disaggregates 2015 27,515
C2.1.D Sum of Age/Sex disaggregates 2015 27,515
C2.1.D Sum of Sex disaggregates 2015 27,515
C2.1.D_NGI By Age: <15 2015 2,482
C2.1.D_NGI By Age: 15+ 2015 25,033
C2.1.D_NGI By Age/Sex: <15 Female 2015 1,241
C2.1.D_NGI By Age/Sex: <15 Male 2015 1,241
C2.1.D_NGI By Age/Sex: 15+ Female 2015 16,522
C2.1.D_NGI By Age/Sex: 15+ Male 2015 8,511
C2.1.D_NGI By Sex: Female 2015 17,763
C2.1.D_NGI By Sex: Male 2015 9,752
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 27,515
C2.1.D_NGI Sum of Age disaggregates 2015 27,515
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 27,515
C2.1.D_NGI Sum of Sex disaggregates 2015 27,515
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 27,515
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 26,139
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 27,515
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 523
CARE_CURR Age/sex: <1 Female 2015 41
CARE_CURR Age/sex: <1 Male 2015 41
CARE_CURR Age/sex: 1-4 Female 2015 269
CARE_CURR Age/sex: 1-4 Male 2015 283
CARE_CURR Age/sex: 10-14 Female 2015 373
CARE_CURR Age/sex: 10-14 Male 2015 376
CARE_CURR Age/sex: 15-19 Female 2015 331
CARE_CURR Age/sex: 15-19 Male 2015 200
CARE_CURR Age/sex: 20-24 Female 2015 1,374
CARE_CURR Age/sex: 20-24 Male 2015 371
CARE_CURR Age/sex: 25-49 Female 2015 11,735
CARE_CURR Age/sex: 25-49 Male 2015 5,584
CARE_CURR Age/sex: 5-9 Female 2015 495
CARE_CURR Age/sex: 5-9 Male 2015 479
CARE_CURR Age/sex: 50+ Female 2015 2,256
CARE_CURR Age/sex: 50+ Male 2015 1,931
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,178
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 1,179
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 15,696
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 8,086
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 26,139
CARE_CURR Sum of Age/Sex disaggregates 2015 26,139
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 26,139
CARE_NEW Age/sex: <1 Female 2015 7
CARE_NEW Age/sex: <1 Male 2015 7
CARE_NEW Age/sex: 1-4 Female 2015 49
CARE_NEW Age/sex: 1-4 Male 2015 52
CARE_NEW Age/sex: 10-14 Female 2015 69
CARE_NEW Age/sex: 10-14 Male 2015 68
CARE_NEW Age/sex: 15-19 Female 2015 71
CARE_NEW Age/sex: 15-19 Male 2015 31
CARE_NEW Age/sex: 20-24 Female 2015 131
CARE_NEW Age/sex: 20-24 Male 2015 129
CARE_NEW Age/sex: 25-49 Female 2015 1,971
CARE_NEW Age/sex: 25-49 Male 2015 1,099
CARE_NEW Age/sex: 5-9 Female 2015 90
CARE_NEW Age/sex: 5-9 Male 2015 87
CARE_NEW Age/sex: 50+ Female 2015 681
CARE_NEW Age/sex: 50+ Male 2015 211
CARE_NEW Aggregated Age/sex: <15 Female 2015 215
CARE_NEW Aggregated Age/sex: <15 Male 2015 214
CARE_NEW Aggregated Age/sex: 15+ Female 2015 2,854
CARE_NEW Aggregated Age/sex: 15+ Male 2015 1,470
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 4,753
CARE_NEW Sum of Age/sex disaggregates 2015 4,753
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 4,753
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 9
CARE_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing clinical care services 2015 9
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 9
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 9
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 9
CARE_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
FN_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 8
FN_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 9
FN_SITE Number of PEPFAR-supported sites achieving 90% nutrition assessments that result in accurate categorization of malnutrition 2015 8
FN_SITE Sum of Numerator Support Type disaggregates 2015 8
FN_SITE Total number of PEPFAR-supported sites providing nutrition assessment, counseling and support (NACS) services 2015 9
FN_SITE_den Sum of Denominator Support Type disaggregates 2015 9
FN_THER Age: <1 2015 13
FN_THER Age: 1-4 2015 89
FN_THER Age: 15-17 2015 84
FN_THER Age: 18+ 2015 3,663
FN_THER Age: 5-14 2015 278
FN_THER Aggregated Age: <18 2015 464
FN_THER Aggregated Age: 18+ 2015 3,663
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2015 4,127
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2015 5,503
FN_THER Sum of Age disaggregates 2015 4,127
FN_THER Sum of Aggregated Age disaggregates 2015 4,127
FPINT_SITE By site support type: Direct Service Delivery (DSD): Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 7
FPINT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported HIV service delivery points 2015 9
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2015 7
FPINT_SITE Service delivery type: Clinical 2015 7
FPINT_SITE Sum of Numerator Site Support Type disaggregates 2015 7
FPINT_SITE Sum of Service Delivery Type disaggregates 2015 7
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2015 9
FPINT_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
HTS_TST Age/sex: 1-4 Female 2015 1,220
HTS_TST Age/sex: 1-4 Female 2015 1,220
HTS_TST Age/sex: 1-4 Male 2015 1,220
HTS_TST Age/sex: 1-4 Male 2015 1,220
HTS_TST Age/sex: 10-14 Female 2015 871
HTS_TST Age/sex: 10-14 Female 2015 871
HTS_TST Age/sex: 10-14 Male 2015 871
HTS_TST Age/sex: 10-14 Male 2015 871
HTS_TST Age/sex: 15-19 Female 2015 1,743
HTS_TST Age/sex: 15-19 Female 2015 1,743
HTS_TST Age/sex: 15-19 Male 2015 1,743
HTS_TST Age/sex: 15-19 Male 2015 1,743
HTS_TST Age/sex: 20-24 Female 2015 4,357
HTS_TST Age/sex: 20-24 Female 2015 4,357
HTS_TST Age/sex: 20-24 Male 2015 4,357
HTS_TST Age/sex: 20-24 Male 2015 4,357
HTS_TST Age/sex: 25-49 Female 2015 6,971
HTS_TST Age/sex: 25-49 Female 2015 6,971
HTS_TST Age/sex: 25-49 Male 2015 6,971
HTS_TST Age/sex: 25-49 Male 2015 6,971
HTS_TST Age/sex: 5-9 Female 2015 523
HTS_TST Age/sex: 5-9 Female 2015 523
HTS_TST Age/sex: 5-9 Male 2015 523
HTS_TST Age/sex: 5-9 Male 2015 523
HTS_TST Age/sex: 50+ Female 2015 1,743
HTS_TST Age/sex: 50+ Female 2015 1,743
HTS_TST Age/sex: 50+ Male 2015 1,743
HTS_TST Age/sex: 50+ Male 2015 1,743
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 2,614
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 2,614
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 14,814
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 14,814
HTS_TST Aggregated Age/sex: <15 Female 2015 2,614
HTS_TST Aggregated Age/sex: <15 Male 2015 2,614
HTS_TST Aggregated Age/sex: 15+ Female 2015 14,814
HTS_TST Aggregated Age/sex: 15+ Male 2015 14,814
HTS_TST By Test Result: Negative 2015 33,462
HTS_TST By Test Result: Negative 2015 33,462
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 34,856
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 34,856
HTS_TST Sum of Age/Sex disaggregates 2015 34,856
HTS_TST Sum of Age/Sex disaggregates 2015 34,856
HTS_TST Sum of Aggregated Age/Sex <15 2015 5,228
HTS_TST Sum of Aggregated Age/Sex <15 2015 5,228
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 29,628
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 29,628
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 34,856
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 34,856
HTS_TST Sum of Test Result disaggregates 2015 34,856
HTS_TST Sum of Test Result disaggregates 2015 34,856
HTS_TST_POS By Test Result: Positive 2015 1,394
HTS_TST_POS By Test Result: Positive 2015 1,394
KP_MAT Number of people who inject drugs (PWID) on medication assisted therapy (MAT) for at least 6 months 2015 300
KP_MAT Sex: Female 2015 60
KP_MAT Sex: Male 2015 240
KP_MAT Sum of Sex disaggregates 2015 300
KP_PREV By key population type: Females who inject drugs (Female PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2015 200
KP_PREV By key population type: Males who inject drugs (Male PWID) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2015 800
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2015 1,000
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 3
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 3
LAB_CAP Sum of Site Support Type disaggregates 2015 3
OVC_ACC Age: <1 2015 30
OVC_ACC Age: 1-4 2015 180
OVC_ACC Age: 10-14 2015 540
OVC_ACC Age: 15-17 2015 300
OVC_ACC Age: 18+ 2015 75
OVC_ACC Age: 5-9 2015 375
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2015 1,500
OVC_ACC Sex: Female 2015 750
OVC_ACC Sex: Male 2015 750
OVC_ACC Sum of Age disaggregates 2015 1,500
OVC_ACC Sum of Sex disaggregates 2015 1,500
OVC_SERV Age: <1 2015 60
OVC_SERV Age: 1-4 2015 360
OVC_SERV Age: 10-14 2015 1,080
OVC_SERV Age: 15-17 2015 600
OVC_SERV Age: 18+ 2015 150
OVC_SERV Age: 5-9 2015 750
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2015 3,000
OVC_SERV Sex: Female 2015 1,500
OVC_SERV Sex: Male 2015 1,500
OVC_SERV Sum of Age disaggregates 2015 3,000
OVC_SERV Sum of Sex disaggregates 2015 3,000
PMTCT_ARV Life-long ART (including Option B+) 2015 692
PMTCT_ARV Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 231
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 923
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 923
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 369
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 323
PMTCT_ARV Sum of New and Current disaggregates 2015 692
PMTCT_ARV Sum of Regimen Type disaggregates 2015 923
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 692
PMTCT_ARV_NGI Maternal AZT (prophylaxis component of WHO Option A during pregnancy and delivery) 2015 231
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 923
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 923
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 369
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 323
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 692
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 923
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 554
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 184
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 37
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 923
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 738
PMTCT_EID Sum of Infant Age disaggregates 2015 738
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 9
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 9
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 9
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 9
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 9
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 9
PMTCT_STAT By: Known positives at entry 2015 434
PMTCT_STAT By: Number of new positives identified 2015 489
PMTCT_STAT Number of new ANC and L&D clients 2015 4,959
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 4,959
PMTCT_STAT Sum of Positives Status disaggregates 2015 923
PMTCT_STAT_NGI By: Known positives at entry 2015 434
PMTCT_STAT_NGI By: Number of new positives identified 2015 489
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 4,959
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 4,959
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 923
QI_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented results in the last 6 months 2015 8
QI_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, HTC 2015 9
QI_SITE Number of PEPFAR-supported clinical service sites with a quality improvement activity completed that addresses clinical HIV programs and has documented process results in the last 6 months 2015 8
QI_SITE Sum of Numerator Site Support Type disaggregates 2015 8
QI_SITE Total number of PEPFAR-supported sites for any HIV clinical service including HIV Care, HIV Treatment, TB care, PMTCT, VMMC, and HTC 2015 9
QI_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: Food and Nutrition Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: Key Populations Prevention Direct Service Delivery (DSD) 2015 2
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 3
SITE_SUPP By program area/support type: OVC Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: PHDP/Family Planning & Integration Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 9
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 5
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 9
SITE_SUPP Number of unique sites supported by PEPFAR 2015 9
TB_ART Age: 0-4 2015 29
TB_ART Age: 15+ 2015 1,068
TB_ART Age: 5-14 2015 79
TB_ART Aggregated Age: <15 2015 108
TB_ART Aggregated Age: 15+ 2015 1,068
TB_ART Female 2015 541
TB_ART Known HIV-positive 2015 471
TB_ART Male 2015 635
TB_ART Newly tested 2015 705
TB_ART Sum of Aggregated Age disaggregates 2015 1,176
TB_ART Sum of Sex disaggregates 2015 1,176
TB_ART Sum of Test Status disaggregates 2015 1,176
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2015 1,307
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2015 1,176
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units 2015 5
TB_ARTSITE By site support type: Direct Service Delivery (DSD): The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 5
TB_ARTSITE Sum of Numerator Site Support Type disaggregates 2015 5
TB_ARTSITE The number of PEPFAR-supported TB basic management units 2015 5
TB_ARTSITE The number of PEPFAR-supported TB basic management units at which 80% of registered TB cases who are HIV-positive are on ART, during the reporting period 2015 5
TB_ARTSITE_den Sum of Denominator Site Support Type disaggregates 2015 5
TB_SCREEN Age: <1 2015 79
TB_SCREEN Age: 1-4 2015 536
TB_SCREEN Age: 10-14 2015 728
TB_SCREEN Age: 15-19 2015 502
TB_SCREEN Age: 20-24 2015 1,674
TB_SCREEN Age: 25-49 2015 16,444
TB_SCREEN Age: 5-9 2015 946
TB_SCREEN Age: 50+ 2015 3,923
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2015 2,289
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2015 22,543
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 26,139
TB_SCREEN Sex: Female 2015 16,023
TB_SCREEN Sex: Male 2015 8,809
TB_SCREEN Sum of Age disaggregates 2015 2,791
TB_SCREEN Sum of Aggregated Age disaggregates 2015 24,832
TB_SCREEN Sum of Sex disaggregates 2015 24,832
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 24,832
TX_CURR Age/Sex: <1 Female 2015 32
TX_CURR Age/Sex: <1 Male 2015 32
TX_CURR Age/Sex: 1-4 Female 2015 214
TX_CURR Age/Sex: 1-4 Male 2015 214
TX_CURR Age/Sex: 15+ Female 2015 12,008
TX_CURR Age/Sex: 15+ Male 2015 6,466
TX_CURR Age/Sex: 5-14 Female 2015 669
TX_CURR Age/Sex: 5-14 Male 2015 670
TX_CURR Aggregated Age/Sex: <1 Female 2015 32
TX_CURR Aggregated Age/Sex: <1 Male 2015 32
TX_CURR Aggregated Age/Sex: <15 Female 2015 915
TX_CURR Aggregated Age/Sex: <15 Male 2015 916
TX_CURR Aggregated Age/Sex: 15+ Female 2015 12,008
TX_CURR Aggregated Age/Sex: 15+ Male 2015 6,466
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 20,305
TX_CURR Percent children with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 74
TX_CURR Percent women and girls with advanced HIV infection receiving antiretroviral therapy (ART) [CURRENT] 2015 73
TX_CURR Sum of age/sex disaggregates 2015 1,831
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,831
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 18,474
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 20,305
TX_CURR_NGI Age/Sex: <1 Female 2015 32
TX_CURR_NGI Age/Sex: <1 Male 2015 32
TX_CURR_NGI Age/Sex: 1-4 Female 2015 214
TX_CURR_NGI Age/Sex: 1-4 Male 2015 214
TX_CURR_NGI Age/Sex: 15+ Female 2015 12,008
TX_CURR_NGI Age/Sex: 15+ Male 2015 6,466
TX_CURR_NGI Age/Sex: 5-14 Female 2015 669
TX_CURR_NGI Age/Sex: 5-14 Male 2015 670
TX_CURR_NGI Aggregated Age/Sex: <1 Female 2015 32
TX_CURR_NGI Aggregated Age/Sex: <1 Male 2015 32
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 915
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 916
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 12,008
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 6,466
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 20,305
TX_CURR_NGI Sum of Age/Sex disaggregates 2015 20,305
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 1,831
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 18,474
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 20,305
TX_DIST Number of Districts with documented routine supportive supervision visits to 75% of HIV care and treatment sites supported by the District 2015 3
TX_DIST Total number of PEPFAR supported District Health Offices 2015 3
TX_NEW Aggregated Grouping by Age: <1 Male 2015 77
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 77
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 257
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 256
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 2,032
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 1,094
TX_NEW Breastfeeding status 2015 32
TX_NEW By Age/Sex: <1 Female 2015 77
TX_NEW By Age/Sex: <1 Male 2015 77
TX_NEW By Age/Sex: 1-4 Female 2015 44
TX_NEW By Age/Sex: 1-4 Male 2015 44
TX_NEW By Age/Sex: 10-14 Female 2015 59
TX_NEW By Age/Sex: 10-14 Male 2015 58
TX_NEW By Age/Sex: 15-19 Female 2015 43
TX_NEW By Age/Sex: 15-19 Male 2015 27
TX_NEW By Age/Sex: 20-24 Female 2015 178
TX_NEW By Age/Sex: 20-24 Male 2015 50
TX_NEW By Age/Sex: 25-49 Female 2015 1,519
TX_NEW By Age/Sex: 25-49 Male 2015 756
TX_NEW By Age/Sex: 5-9 Female 2015 77
TX_NEW By Age/Sex: 5-9 Male 2015 77
TX_NEW By Age/Sex: 50+ Female 2015 292
TX_NEW By Age/Sex: 50+ Male 2015 261
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 3,639
TX_NEW Pregnancy status 2015 291
TX_NEW Sum of Age/Sex disaggregates 2015 3,639
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 3,639
TX_RET Age: 0-4 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 78
TX_RET Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 2,846
TX_RET Age: 5-14 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 211
TX_RET Aggregated Age: <15 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 289
TX_RET Aggregated Age: 15+ (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 2,846
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 3,134
TX_RET Pregnancy and breastfeeding status (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2015 577
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 3,688
TX_RET_den Age: 0-4 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 91
TX_RET_den Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 3,348
TX_RET_den Age: 5-14 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 249
TX_RET_den Aggregated Age: <15 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 340
TX_RET_den Aggregated Age: 15+ (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 3,348
TX_RET_den Pregnancy and breastfeeding status (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2015 679
TX_SITE By support type: Direct Service Delivery (DSD): Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 7
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 9
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 7
TX_SITE Sum of Numerator Site Support Type disaggregates 2015 7
TX_SITE Total number of PEPFAR-supported ART sites 2015 9
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 9
Cross Cutting Budget Categories and Known Amounts Total: $1,325,000
Human Resources for Health $960,000
Renovation $100,000
Gender: Gender Based Violence (GBV) $90,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Monitoring and Evaluation
Gender: Gender Equality $90,000
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Monitoring and Evaluation
Economic Strengthening $25,000
Education $60,000
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning